Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
Katharina Schmalstieg-BahrDavid J GladstoneEva HummersJohanna SuerbaumJeffrey S HealeyAntonia ZapfDenise KösterStefanie M WerhahnRolf WachterPublished in: The European journal of general practice (2024)
Natriuretic peptide levels and hsTnI are higher in patients with AF than without and may help select patients for AF screening, but larger trials are needed.
Keyphrases
- atrial fibrillation
- clinical trial
- end stage renal disease
- oral anticoagulants
- ejection fraction
- study protocol
- left atrial
- catheter ablation
- newly diagnosed
- chronic kidney disease
- heart failure
- open label
- direct oral anticoagulants
- prognostic factors
- randomized controlled trial
- high throughput
- phase iii
- phase ii
- percutaneous coronary intervention
- left ventricular
- venous thromboembolism
- patient reported outcomes
- placebo controlled